Low-dose Ranibizumab Effective for Retinopathy of Prematurity

Low doses of anti-VEGF therapy with ranibizumab are effective in infants with retinopathy of prematurity (ROP), according to results from the CARE-ROP study.
Reuters Health Information

Full Story →